Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
about
A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortalityShort-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trialSelenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies.Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.Selenium supplementation and prostate cancer mortalityAssociation of obesity and smoking with PSA and PSA velocity in men with prostate cancer.EFFECT OF SELENIUM SUPPLEMENTATION ON PROTEOMIC SERUM BIOMARKERS IN ELDERLY MENRandomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neckMethylselenol, a selenium metabolite, plays common and different roles in cancerous colon HCT116 cell and noncancerous NCM460 colon cell proliferation.Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocityProstate cancer chemoprevention by natural agents: Clinical evidence and potential implications
P2860
Q26782066-85D45451-B48A-48C1-9DF2-94DBD4A8CF19Q27009177-E8861332-DE98-4815-BCD8-483A9EEA996FQ31112967-898D286A-D297-4890-901C-D5F6457AFA3DQ33863562-1340962B-0DA7-4549-90A6-5C53FC1386C9Q34974869-9739CABF-432A-40D6-A6E6-3C1633903FE6Q35924445-7CA17D01-CDF4-486A-9D08-E89B27CD24FEQ36052407-DC81D3D2-13EA-4ADE-B665-D341943B3CC7Q36143844-00C5ECC4-BD3D-4C90-9C68-9EAF790A49B2Q39428110-5B9F8664-787D-41E6-9ACA-01680C61198BQ42424388-FD14DAA7-0008-47ED-8F1F-64A324099153Q57112620-C4C68901-AE9D-49D7-8549-352294701D6B
P2860
Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Oral selenium supplementation ...... for localized prostate cancer.
@ast
Oral selenium supplementation ...... for localized prostate cancer.
@en
type
label
Oral selenium supplementation ...... for localized prostate cancer.
@ast
Oral selenium supplementation ...... for localized prostate cancer.
@en
prefLabel
Oral selenium supplementation ...... for localized prostate cancer.
@ast
Oral selenium supplementation ...... for localized prostate cancer.
@en
P2093
P2860
P1476
Oral selenium supplementation ...... for localized prostate cancer.
@en
P2093
Amit M Algotar
Chiu-Hsieh Hsu
Elizabeth H Slate
Frederick R Ahmann
James Ranger-Moore
Larry C Clark
M Suzanne Stratton
Patricia A Thompson
Steven P Stratton
P2860
P304
P356
10.1158/1940-6207.CAPR-09-0143
P577
2010-07-20T00:00:00Z